Is STIM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for STIM. It does not provide personalized investment advice.

STIM (Neuronetics, Inc. Common Stock) Stock Analysis - Financials

Neuronetics, Inc. Common Stock (STIM) is a publicly traded Healthcare sector company. As of July 14, 2026, STIM trades at $1.79 with a market cap of $122.47M and a P/E ratio of -1.27. STIM moved +2.84% today. Year to date, STIM is +26.95%; over the trailing twelve months it is -49.86%. Its 52-week range spans $0.71 to $5.92. Rallies surfaces STIM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are STIM's key financials?

STIM financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. STIM recently traded at $1.79. Market cap is $122.47M. P/E ratio is -1.27. Revenue is $74.89M.

STIM Key Metrics

Key financial metrics for STIM
Metric	Value
Price	$1.79
Market Cap	$122.47M
P/E Ratio	-1.27
EPS	$-1.38
Dividend Yield	0.00%
52-Week High	$5.92
52-Week Low	$0.71
Volume	1.54M
Avg Volume	0
Revenue (TTM)	$74.89M
Net Income	$-43.73M
Gross Margin	72.32%

STIM Analyst Consensus

STIM analyst coverage data. Average price target: $0.00.

Common questions about STIM

What are STIM's key financials?: STIM financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. STIM recently traded at $1.79. Market cap is $122.47M. P/E ratio is -1.27. Revenue is $74.89M.
Is STIM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for STIM. It does not provide personalized investment advice.